Skip to main content

Table 4 AEs during 30-day follow-up

From: Effects of omeprazole or pantoprazole on platelet function in non-ST-segment elevation acute coronary syndrome patients receiving clopidogrel

Characteristic Omeprazole group (n = 303) Pantoprazole group (n = 304) P value
Stent thrombosis [n (%)] 0 1 (0.3) 1.00
MACEs [n (%)] 7 (2.3) 5 (1.6) 0.58
 Cardiac death 1 (0.3) 0 0.50
 Myocardial infarction 0 0
 Ischemic symptoms driven target vessel revascularization 1 (0.3) 0 0.50
 Non-target vessel revascularization 5 (1.7) 5 (1.6) 1.00
Recurrent angina [n (%)] 19 (6.3) 12 (3.9) 0.20
All-cause death [n (%)] 1 (0.3)a 0 0.50
TIMI bleeding events [n (%)]
 Major 0 0
 Moderate 0 0
 Minor 4 (1.3) 8 (2.6) 0.38
Stroke [n (%)] 0 0
Adverse drug reactions [n (%)] 23 (7.6) 29 (9.5) 0.47
AEs [n (%)] 46 (15.2) 45 (14.8) 0.91
  1. aOne patient died due to brain injury in the omeprazole group